Christoph Kreer

13PUBLICATIONS
94CO-AUTHORS
Predictive and prognostic markersInnate immunityMolecular targetsTumour immunologyMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 23, 2026
Investigation of Vaccine-Induced Immune Response After Vaccination Against Respiratory Viruses in Immunocompromised Patients With or Without Hemato-Oncological Diseases (RESPONSE): Protocol for a Prospective Cohort Study.

|Feb 03, 2026
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332gp120 glycan-independent epitope.

Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde

|Dec 08, 2025
ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer.

Lydia Meder, Charlotte I Orschel, Cyrielle L Bouchez

|Oct 06, 2025
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy.

Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde

|Sep 18, 2025
Identification of a broad and potent V3 glycan site bNAb targeting an N332gp120 glycan-independent epitope.

Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde

|Sep 05, 2025
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy.

Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde

Pageof 3

Frequent Collaborators

11 joint publications

Henning Gruell

10 joint publications

Florian Klein

5 joint publications

Jesse D Bloom

4 joint publications

Philipp Schommers